p. 1−11
2357-061X
Vol.42/No.1
3 mm), nodule in a cyst wall ], b- Doppler indices (resistance index and pulsatility index), c- CA125 serum level, and d- histopathological examination findings after laparotomy. Results: The histopathology identified 20 benign(B) and 84 malignant(M) ovarian masses. The benign tumors were 9(45%) endometroitic cyst, 6(30%) pseudomucinous cystadenoma and 5(25%) serous cystadenoma. The malignant ones included 43(51.2%) papillary serous cytadenocarcinoma 18(21.4%) endometrioid adenocarcinoma, 10(11.9%) pseudomucinous cystadenocarcinoma, 5(5.9%) clear cell adenocarcinoma, 2(2.4%) papillary serous borderline cystadenocarcinoma, 2(2.4%) borderline serous adenocarcinoma, 1(1.2%) serous adenocarcinoma, 1(1.2%) borderline endometroid adenocarcinoma, 1(1.2%) dysgerminoma and 1(1.2%) Pseudomucinous borderline cystadenocarcinoma]. The US showed no morphological signs of malignancy in 10 [9.6% (9 M vs 1 B)] masses, thick cyst wall and mixed solid & cystic components 1(1%) M; thick cyst wall1 and nodule in the cyst wall 1(1%) M, mixed solid and cystic components 15[14.4% (14 M vs 1 B)], solid components 17(16.3%) M, thick cyst wall (> 3 mm) 27[26% (10 M vs 17 B)] and nodules in the cyst wall in 33[31.7% (32 M vs 1 B)] masses. Doppler studies of ovarian mass vasculature showed that< 0.4 resistance index and p< 0.001) while CA125 serum cutoff level 30 IU/ ml alone failed to differentiate between the benign and malignant masses. Conclusion: using CA125 serum cutoff level 30 IU/ ml combined with US grey scale or color Doppler examination can discriminate between benign and malignant adnexal masses especially in positive Doppler indices.]]>
p. 12−24
2357-061X
Vol.42/No.1
p. 25−44
2357-061X
Vol.42/No.1
p. 45−62
2357-061X
Vol.42/No.1
p. 63−81
2357-061X
Vol.42/No.1
p. 82−102
2357-061X
Vol.42/No.1